LCG Systems Awarded CIO-SP3 IDIQ Contract by National Institutes of Health

announced today that it has beenselected by the(NIH)as an awardee for the agency's IT Services/Solutions Government-Wide Acquisition Contract (GWAC). The contract, administered by , is a 10-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a ceiling of $20 billion available for use by any Federal civilian or Department of Defense agency. The contract's focus is on health and biomedical-related IT Services, and can be used for acquisitions across a broad base of functional areas.

Via CIO-SP3, LCG Systems will provide the depth and breadth of scope required to implement complex IT solutions in the Federal sector. LCG Systems is eligible to compete for task orders in 10 functional areas including IT Services for Biomedical Research, Health Sciences, and Healthcare; Chief Information Officer (CIO) Support; Imaging; Outsourcing; IT Operations and Maintenance; Integration Services; Critical Infrastructure Protection and Information Assurance; Digital Government; Enterprise Management Systems; and Software Development.

"We are very pleased to receive an award on CIO-SP3 Small Business in all ten functional areas. CIO-SP3's vetted contract holders, rapid acquisition process, and low cost make it a contract vehicle of choice for Federal agencies. Using CIO-SP3, LCG Systems and our teaming partners will be able to fully support the needs of Federal agencies with a wide variety of missions; especially those that are health related," says Conrad Kenley, CEO of LCG Systems.

Founded by Conrad Kenley in 1990, . is a leader in providing grants management solutions to health and social services agencies. LCG Systems (a subsidiary of LCG, Inc.) was incorporated in 2002 as a (SDB) to focus on the growing demand for quality health information technology services to the Federal Government.

For more information on visit the website at or call 1.301.984.4004.

Suggested Articles

German scientists are targeting a protein-cutting enzyme that many viruses, including the coronavirus COVID-19, need to replicate.

The 100 largest companies trading on the London Stock Exchange have boosted the percentage of women on their boards, but has life sciences kept pace?

In this week's EuroBiotech Report, Bicycle lands Genentech collaboration, GSK inks COVOD-19 adjuvant deal and Grifols buys antibiotic assets.